title: Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis.
abstract: Mutant p53 proteins not only lose their tumor-suppressor function but some acquire oncogenic gain of function (GOF). The published mutp53 knock-in (KI) alleles (R172H, R270H, R248W) manifest GOF by broader tumor spectrum and more metastasis compared with the p53-null allele, but do not shorten survival. However, whether GOF also occurs with other mutations and whether they are all biologically equal is unknown. To answer this, we created novel humanized mutp53 KI mice harboring the hot spot alleles R248Q and G245S. Intriguingly, their impact was very different. Compared with p53-null mice, R248Q/- mice had accelerated onset of all tumor types and shorter survival, thus unprecedented strong GOF. In contrast, G245S/- mice were similar to null mice in tumor latency and survival. This was associated with a twofold higher T-lymphoma proliferation in R248Q/- mice compared with G245S/- and null mice. Moreover, R248Q/- hematopoietic and mesenchymal stem cells were expanded relative to G245S/- and null mice, the first indication that GOF also acts by perturbing pretumorous progenitor pools. Importantly, these models closely mirror Li-Fraumeni patients who show higher tumor numbers, accelerated onset and shorter tumor-free survival by 10.5 years when harboring codon R248Q mutations as compared with Li-Fraumeni patients with codon G245S mutations or p53 deletions/loss. Conversely, both KI alleles caused a modest broadening of tumor spectrum with enhanced Akt signaling compared with null mice. These models are the first in vivo proof for differential oncogenic strength among p53 GOF alleles, with genotype-phenotype correlations borne out in humans.
authors.affiliation: Department of Pathology, Stony Brook University, Stony Brook, NY 11794, USA.
authors.forename: W
authors.initials: W
authors.lastname: Hanel
authors.forename: N
authors.initials: N
authors.lastname: Marchenko
authors.forename: S
authors.initials: S
authors.lastname: Xu
authors.forename: S Xiaofeng
authors.initials: SX
authors.lastname: Yu
authors.forename: W
authors.initials: W
authors.lastname: Weng
authors.forename: U
authors.initials: U
authors.lastname: Moll
mesh_terms: D000328:Adult; D000483:Alleles; D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D004195:Disease Models, Animal; D006801:Humans; D016864:Li-Fraumeni Syndrome / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D016399:Lymphoma, T-Cell / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009154:Mutation / Q000235:genetics*; D051057:Proto-Oncogene Proteins c-akt / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000235:genetics* / Q000502:physiology*
chemical_list: D016159:Tumor Suppressor Protein p53; D051057:Proto-Oncogene Proteins c-akt
references.citation: Cancer Genet Cytogenet. 2003 Aug;145(1):60-4
references.pmid: 12885464
references.citation: Oncogene. 2010 Feb 18;29(7):949-56
references.pmid: 19881536
references.citation: Oncogene. 1998 Sep 3;17(9):1061-8
references.pmid: 9764816
references.citation: Blood. 2002 Jul 1;100(1):246-58
references.pmid: 12070034
references.citation: Cell Stem Cell. 2009 Jan 9;4(1):37-48
references.pmid: 19128791
references.citation: Am J Pathol. 1997 Jan;150(1):1-13
references.pmid: 9006316
references.citation: Science. 1991 Jul 5;253(5015):49-53
references.pmid: 1905840
references.citation: Cancer Res. 2009 Apr 1;69(7):3213-20
references.pmid: 19293180
references.citation: Am J Pathol. 1994 Sep;145(3):702-14
references.pmid: 8080050
references.citation: Oncogene. 2012 May 24;31(21):2680-90
references.pmid: 21963848
references.citation: Nat Genet. 2000 May;25(1):47-54
references.pmid: 10802655
references.citation: Oncogene. 2001 Jan 18;20(3):320-8
references.pmid: 11313961
references.citation: Cancer Genet Cytogenet. 2004 May;151(1):36-51
references.pmid: 15120909
references.citation: Cancer Cell. 2011 Aug 16;20(2):246-59
references.pmid: 21840488
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2948-53
references.pmid: 11867759
references.citation: J Med Genet. 2008 Aug;45(8):535-8
references.pmid: 18511570
references.citation: J Cell Biochem. 2012 Feb;113(2):433-9
references.pmid: 22006292
references.citation: Immunity. 1999 Jun;10(6):691-700
references.pmid: 10403644
references.citation: Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107
references.pmid: 20182618
references.citation: Cancer Cell. 2006 Feb;9(2):109-20
references.pmid: 16473278
references.citation: Science. 1994 Jul 15;265(5170):346-55
references.pmid: 8023157
references.citation: Cancer Res. 2000 Dec 15;60(24):6788-93
references.pmid: 11156366
references.citation: Cell. 2009 Sep 18;138(6):1083-95
references.pmid: 19766563
references.citation: Biomed Res. 2010 Dec;31(6):401-11
references.pmid: 21187651
references.citation: Cell. 2009 Dec 24;139(7):1327-41
references.pmid: 20064378
references.citation: Hum Mutat. 2007 Jun;28(6):622-9
references.pmid: 17311302
references.citation: Genes Dev. 2012 Jun 15;26(12):1268-86
references.pmid: 22713868
references.citation: Cell. 2004 Dec 17;119(6):847-60
references.pmid: 15607980
references.citation: Nat Chem Biol. 2011 May;7(5):285-95
references.pmid: 21445056
references.citation: Nat Cell Biol. 2007 May;9(5):573-80
references.pmid: 17417627
references.citation: Genes Dev. 2008 May 15;22(10):1337-44
references.pmid: 18483220
references.citation: Cell. 2004 Dec 17;119(6):861-72
references.pmid: 15607981
references.citation: Development. 2006 Jan;133(2):363-9
references.pmid: 16368933
references.citation: Biochim Biophys Acta. 2009 May;1787(5):414-20
references.pmid: 19007744
references.citation: J Cell Sci. 2008 Jun 1;121(11):1899-906
references.pmid: 18477611
references.citation: Nat Rev Cancer. 2001 Oct;1(1):68-76
references.pmid: 11900253
references.citation: Curr Biol. 1994 Jan 1;4(1):1-7
references.pmid: 7922305
references.citation: Blood. 2002 Jul 1;100(1):238-45
references.pmid: 12070033